Oral pharmaceutical formulation in the form of a plurality...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/52 (2006.01) A61K 9/50 (2006.01)

Patent

CA 2493453

The invention concerns microcapsules with prolonged release of active principles with low solubility, consisting of a core containing the active principle and coated with a polymer layer which controls the release of the active principle. The aim is that said oral microcapsules containing hardly soluble active principles, should have a coating film of sufficient thickness to ensure controlled permeability and should be adapted to industrial reproduction. This is achieved by the inventive microcapsules of mean diameter less than 1000 microns, and whereof the coating film contains a film-forming polymer (P1) insoluble in gastrointestinal tract fluids, a water-soluble polymer (P2), a plasticizer (PL), and optionally a lubricating surfactant (TA). Said microcapsules are characterized in that their coating films represents at least 3 % p/p of dry matter, relative to their total weight and their core contains a hardly soluble active principle and a solubilizing agent (polyoxyethylene hydrogenated castor oil) which provides the core wherein it is contained with properties such that the behaviour of the exposed core (non-coated) in a given dissolving test (TD), is as follows: release of 80 % of active principle in less than two hours. The invention also concerns the use of such microcapsules in galenic formulation.

L'invention concerne des microcapsules à libération prolongée de principes actifs (PA) de faible solubilité, constituées d'un coeur contenant le PA et enrobé d'une couche de polymère qui contrôle la libération du PA. Le but est que ces microcapsules orales de PA peu soluble, aient une pellicule d'enrobage d'épaisseur suffisante pour assurer une perméabilité contrôlée et industriellement reproductible. Ce but est atteint par les microcapsules selon l'invention de diamètre moyen est inférieur à 1000 microns, et dont la pellicule d'enrobage contient un polymère filmogène (P1) insoluble dans les liquides du tractus gastro-intestinal ; un polymère hydrosoluble (P2) ; un plastifiant (PL) ; et éventuellement un agent tensioactif (TA) lubrifiant ;qui sont caractérisées en ce que leur pellicule d'enrobage représente au moins 3 % p/p sec, de leur masse totale, et leur c ur contient un PA peu soluble et un agent solubilisant (huile de ricin hydrogénée polyoxyéthylènée ) qui confère au coeur dans lequel il est inclus des propriétés telles que le comportement du coeur nu (non enrobé) dans un test de dissolution TD donné, est le suivant: libération de 80 % du PA en moins de deux heures. L'invention concerne aussi les applications desdites microcapsules en galénique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oral pharmaceutical formulation in the form of a plurality... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral pharmaceutical formulation in the form of a plurality..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral pharmaceutical formulation in the form of a plurality... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1517950

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.